Cite
Lynch M, Malara A, Timoney I, et al. Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial. Dermatology. 2021;238(1):140-147doi: 10.1159/000514494.
Lynch, M., Malara, A., Timoney, I., Vencken, S., Ahern, T., Awdeh, F., Sweeney, C., Galligan, M., Kelly, G., Hughes, R., Murad, A., Hambly, R., O'Shea, D., Doran, P., & Kirby, B. (2022). Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial. Dermatology (Basel, Switzerland), 238(1), 140-147. https://doi.org/10.1159/000514494
Lynch, Maeve, et al. "Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial." Dermatology (Basel, Switzerland) vol. 238,1 (2022): 140-147. doi: https://doi.org/10.1159/000514494
Lynch M, Malara A, Timoney I, Vencken S, Ahern T, Awdeh F, Sweeney C, Galligan M, Kelly G, Hughes R, Murad A, Hambly R, O'Shea D, Doran P, Kirby B. Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial. Dermatology. 2022;238(1):140-147. doi: 10.1159/000514494. Epub 2021 Apr 16. PMID: 33866313.
Copy
Download .nbib